A review of real-world data on the effects of aripiprazole on weight and metabolic outcomes in adults
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A review of real-world data on the effects of aripiprazole on weight and metabolic outcomes in adults
Authors
Keywords
-
Journal
CURRENT MEDICAL RESEARCH AND OPINION
Volume 30, Issue 8, Pages 1629-1641
Publisher
Informa Healthcare
Online
2014-03-26
DOI
10.1185/03007995.2014.908280
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis
- (2013) Stefan Leucht et al. LANCET
- Body Weight and Metabolic Adverse Effects of Asenapine, Iloperidone, Lurasidone and Paliperidone in the Treatment of Schizophrenia and Bipolar Disorder
- (2012) Marc De Hert et al. CNS DRUGS
- Switching Antipsychotic Medications: Not Enough, Too Often, or Just Right?
- (2011) Peter J. Weiden AMERICAN JOURNAL OF PSYCHIATRY
- A Randomized Trial Examining the Effectiveness of Switching From Olanzapine, Quetiapine, or Risperidone to Aripiprazole to Reduce Metabolic Risk: Comparison of Antipsychotics for Metabolic Problems (CAMP)
- (2011) T. Scott Stroup et al. AMERICAN JOURNAL OF PSYCHIATRY
- Association between second-generation antipsychotics and newly diagnosed treated diabetes mellitus: does the effect differ by dose?
- (2011) Marianne Ulcickas Yood et al. BMC Psychiatry
- The Impact of the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) on Prescribing Practices
- (2011) Rachel L. Berkowitz et al. JOURNAL OF CLINICAL PSYCHIATRY
- A real-world data analysis of dose effect of second-generation antipsychotic therapy on hemoglobin A1C level
- (2011) Zhenchao Guo et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Effectiveness of maintenance treatments with atypical and typical antipsychotics in stable schizophrenia with early stage: 1-year naturalistic study
- (2011) Xiaofeng Guo et al. PSYCHOPHARMACOLOGY
- Metabolic Testing Rates in 3 State Medicaid Programs After FDA Warnings and ADA/APA Recommendations for Second-Generation Antipsychotic Drugs
- (2010) Elaine H. Morrato et al. ARCHIVES OF GENERAL PSYCHIATRY
- Treatment with antipsychotics and the risk of diabetes in clinical practice
- (2010) Lars Vedel Kessing et al. BRITISH JOURNAL OF PSYCHIATRY
- Antipsychotics Associated with the Development of Type 2 Diabetes in Antipsychotic-Naïve Schizophrenia Patients
- (2010) Jimmi Nielsen et al. NEUROPSYCHOPHARMACOLOGY
- A retrospective comparison of BMI changes and the potential risk factors among schizophrenic inpatients treated with aripiprazole, olanzapine, quetiapine or risperidone
- (2010) Seung-Yup Lee et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Trial of aripiprazole in the treatment of first-episode schizophrenia
- (2010) Hwa-Young Lee et al. PSYCHIATRY AND CLINICAL NEUROSCIENCES
- Head-to-head comparisons of metabolic side effects of second generation antipsychotics in the treatment of schizophrenia: A systematic review and meta-analysis
- (2010) Christine Rummel-Kluge et al. SCHIZOPHRENIA RESEARCH
- Effectiveness of Switching to Aripiprazole From Atypical Antipsychotics in Patients With Schizophrenia
- (2009) Sung-Wan Kim et al. CLINICAL NEUROPHARMACOLOGY
- Efficacy and Tolerability of Aripiprazole in First-Episode Drug-Naive Patients With Schizophrenia
- (2009) Hitoshi Takahashi et al. CLINICAL NEUROPHARMACOLOGY
- Major Changes in Glucose Metabolism, Including New-Onset Diabetes, Within 3 Months After Initiation of or Switch to Atypical Antipsychotic Medication in Patients With Schizophrenia and Schizoaffective Disorder
- (2009) Ruud van Winkel et al. JOURNAL OF CLINICAL PSYCHIATRY
- Comparing the Safety and Efficacy of Atypical Antipsychotics in Psychiatric Patients With Comorbid Medical Illnesses
- (2009) John W. Newcomer JOURNAL OF CLINICAL PSYCHIATRY
- Are Weight Gain and Metabolic Side Effects of Atypical Antipsychotics Dose Dependent?
- (2009) Viktoria Simon et al. JOURNAL OF CLINICAL PSYCHIATRY
- Relationship between body mass index and insulin resistance in patients treated with second generation antipsychotic agents
- (2009) Sun H. Kim et al. JOURNAL OF PSYCHIATRIC RESEARCH
- The incidence of diabetes in atypical antipsychotic users differs according to agent-results from a multisite epidemiologic study
- (2009) Marianne Ulcickas Yood et al. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
- Long-term efficacy and safety of aripiprazole in patients with schizophrenia, schizophreniform disorder, or schizoaffective disorder: 26-week prospective study
- (2009) Jun Soo Kwon et al. PSYCHIATRY AND CLINICAL NEUROSCIENCES
- Changes in metabolic parameters following a switch to aripiprazole in Japanese patients with schizophrenia: One-year follow-up study
- (2009) Hiroyoshi Takeuchi et al. PSYCHIATRY AND CLINICAL NEUROSCIENCES
- A 12-month follow-up study of treating overweight schizophrenic patients with aripiprazole
- (2008) S. G. Schorr et al. ACTA PSYCHIATRICA SCANDINAVICA
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started